

Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1267, 2000-01, pp. : 14-14
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Antibacterials for the treatment of CHD?
Inpharma, Vol. 1, Iss. 1386, 2003-01 ,pp. :


PTCA preferable in nonacute CHD?
Inpharma, Vol. 1, Iss. 1246, 2000-01 ,pp. :


Pravastatin for CHD in hypertensive, hypercholesterolaemic patients?
Inpharma, Vol. 1, Iss. 1370, 2003-01 ,pp. :


Rethink use of statins for primary prevention in CHD?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 269, 2000-01 ,pp. :


Homocysteine-lowering therapy cost effective in CHD?
Inpharma, Vol. 1, Iss. 1321, 2002-01 ,pp. :